UNIGE document Scientific Article
previous document  unige:54920  next document
add to browser collection
Title

Joint damage progression in patients with rheumatoid arthritis in clinical remission. Do biologics perform better than synthetic antirheumatic drugs?

Authors
Ciubotariu, Elena
Published in Journal of Rheumatology. 2014, vol. 41, no. 8, p. 1576-1582
Abstract Randomized controlled studies have demonstrated protective advantages of biologic therapies over the synthetic disease-modifying antirheumatic drugs (DMARD) in slowing joint damage progression in patients with rheumatoid arthritis (RA). This effect appears to be largely independent of the clinical disease control. We measured the rate of radiographic progression in patients with RA in clinical remission treated with synthetic versus biologic DMARD.
Identifiers
PMID: 25028383
Full text
Article (Published version) (222 Kb) - document accessible for UNIGE members only Limited access to UNIGE
Structures
Research group Mécanisme de l'inflammation articulaire (44)
Citation
(ISO format)
CIUBOTARIU, Elena, GABAY, Cem, FINCKH, Axel. Joint damage progression in patients with rheumatoid arthritis in clinical remission. Do biologics perform better than synthetic antirheumatic drugs?. In: Journal of Rheumatology, 2014, vol. 41, n° 8, p. 1576-1582. https://archive-ouverte.unige.ch/unige:54920

93 hits

0 download

Update

Deposited on : 2015-03-30

Export document
Format :
Citation style :